At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 37 enrolled
Drug / intervention
Hyaluronic acid fillerdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment and Augmentation of Lip Appearance in Specific Study Populations
In Brief
A Phase 4 clinical trial evaluating Hyaluronic acid filler for Lip Aging and 2 related conditions. Completed, enrolled 37 participants across 1 site.
Detailed Summary
This study aims to learn more about the effects of aging and lip filler treatment on lips and the surrounding skin by comparing, among two different age groups of people, changes in the blood vessels and nerves, volume, color and texture change before and after lip filler treatment and pain tolerance from lip filler treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLip Aging, Lip Augmentation, Lip
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20222023202420252026
First PostedApr 2021
Enrollment StartMay 2021
Primary CompletionJul 2022
Study CompletionAug 2022
TodayJul 2026
First PostedApr 9, 2021
Enrollment StartMay 7, 2021
Primary CompletionJul 1, 2022
Study CompletionAug 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.2 years ago
Interventions
Hyaluronic acid fillerdrug
Hyaluronic acid filler treatment of the lips with Restylane Kysse, which is a FDA approved treatment for lip augmentation.